Gaush Meditech Ltd (incorporated in the Cayman Islands; HKEX: 02407) filed its Monthly Return for Equity Issuer covering the period to 31 May 2026. Key takeaways are as follows:

• Authorised share capital stood unchanged at 500.00 million ordinary shares with a par value of USD 0.0001 each, representing total authorised capital of USD 50,000.

• Issued share capital remained flat at 147.89 million ordinary shares. The company held no treasury shares during the month, leaving total issued shares likewise at 147.89 million.

• There were no movements in share options, warrants, convertible securities or other equity-linked arrangements, and no other share issuances, repurchases or cancellations were recorded.

• Gaush Meditech confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float requirement of 25 percent.

• The board affirmed that all listing rule obligations and relevant regulatory filings have been met, and that no outstanding proceeds or conditions remain in respect of previously issued securities.

Overall, the May 2026 return reflects a stable capital structure with full regulatory compliance and no dilution or treasury share activity during the period.